Question

In CASE 11.1 Association for Molecular Pathology v. Myriad Genetics, Inc.(2013), the U.S. Supreme Court held that under U.S. Patent Laws isolated DNA is:
a. not eligible for patent protection because it is naturally occurring.
b. eligible for patent protection because it is man-made.
c. eligible for patent protection because it is naturally occurring.
d. not eligible for patent protection because it is man-made.

Answer

This answer is hidden. It contains 1 characters.